Mira Pharmaceuticals (MIRA) Other Non-Current Liabilities (2022)

Mira Pharmaceuticals' (MIRA) quarterly Other Non-Current Liabilities came in at $100000.0 in Q4 2022.

Mira Pharmaceuticals (MIRA) Other Non-Current Liabilities (2022) Analysis & Trends

Mira Pharmaceuticals has disclosed Other Non-Current Liabilities across 1 years of filings, most recently posting $100000.0 for Q4 2022.

Other Non-Current Liabilities for Q4 2022 came in at $100000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2022 was $100000.0 (changed N/A YoY), and the FY2022 annual result was $100000.0, changed N/A from the prior year.
Other Non-Current Liabilities came in at $100000.0 for Q4 2022 at Mira Pharmaceuticals.
In the past five years, Other Non-Current Liabilities ranged from a high of $100000.0 in Q4 2022 to a low of $100000.0 in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Gsk	92,316,836.42 Bn	92,316,831.46 Bn	7.76 Bn
2	Eli Lilly	983.57 Bn	978.29 Bn	16.22 Bn
3	Johnson & Johnson	553.56 Bn	531.50 Bn	15.96 Bn
4	AbbVie	383.35 Bn	374.00 Bn	10.78 Bn
5	Merck	281.71 Bn	276.06 Bn	12.09 Bn
6	Amgen	182.20 Bn	170.16 Bn	5.87 Bn
7	Gilead Sciences	153.71 Bn	145.98 Bn	5.52 Bn
8	Pfizer	143.75 Bn	130.98 Bn	-1.21 Bn
9	Bristol Myers Squibb	109.71 Bn	99.25 Bn	8.07 Bn
10	Mira Pharmaceuticals	22.73 Mn	11.70 Mn	-

Download Data

Date	Value
Dec 31, 2022	100,000.00